NTRA: Natera Inc

NTRA新闻

• 18:10 Why Moderna's (MRNA) Cancer Vaccine Matters To Investors
• 15:22 Natera & Angiex Partner to Evaluate AGX101 Response With Signatera
• 08:05 Natera Stock: The Growth May Not Justify Current Levels (NASDAQ:NTRA)
• 14:25 VCYT Drops 25.3% in the Past Month. Is the Sell-Off an Opportunity?
• 16:35 Duquesne Management Opens New Position in Alphabet Stock as Google Posts Blowout Q2 Results
• 14:28 Making Drugs With AI: Biopharma Giants Gear Up For New Arena
• 12:00 Kiniksa's Sales Are Expected To Decline — Why That's All According To Plan
• 12:00 Tempus AI Just Had Their Entire Strategy Validated By Moderna’s Vaccine Advance (TEM)
• 05:06 Natera: Even 30% Annual Growth Through 2030 Doesn't Support $310 Per Share (NASDAQ:NTRA)
• 06:47 Zacks Investment Ideas feature highlights: NVDA, GOOGL, AMZN, INTC and others
• 15:55 13F Season: Where Wall Street's Smart Money is Betting
• 15:44 Natera Supports Kupando Trial to Advance ctDNA Monitoring in Cancer
• 14:29 Stanley Druckenmiller ditched these chip plays before the selloff. Here’s how he’s playing the tech sector now.
• 13:07 Tempus AI's FDA Win Could Unlock Major Reimbursement Growth Ahead
• 14:55 Is Tempus AI Worth Buying as Growth Improves but Valuation Stays High?
• 20:37 Stocks Settle Higher as a Weak Jobs Report Allays Rate Hike Fears
• 15:42 Stocks Supported as Fed Rate Hike Fears Ease
• 14:07 IBD 50 Stock Natera Zips Into Profit-Taking Zone On Its Blowout Quarter
• 14:04 Stocks Rally on Earnings and Fed-Friendly US Payroll Report